Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,444.00    4.00 (0.28%)
Bid:
1,442.00
Ask:
1,448.00
Spread: 6.00 (0.416%)
Market Cap: £494.38m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

11 Jan 2008 07:01

Craneware plc11 January 2008 Craneware plc ("Craneware" or the "Company") H1 TRADING UPDATE 11 January 2008 - Craneware plc, (AIM: CRW) a leader in revenue cyclemanagement software solutions for the US healthcare market, is pleased to givean update today on trading during the half year to 31 December 2007. Following the Company's IPO on AIM in September 2007, Craneware has executed onits strategy to further advance its market leading position. In the six monthsto 31 December 2007, the Company signed up 96 new hospitals, compared to 64 inthe previous corresponding period. As a result, the Company's software is nowbeing used in 878 hospitals in the US, up from 800 at the beginning of the year. Revenue for the first half of the year was in line with management expectations,with new sales bookings being over 50% higher than the previous correspondingperiod. Craneware's flagship product, Chargemaster Toolkit(R), was also onceagain named top in its class by the prestigious industry research house KLAS inthe US. As stated at the time of the IPO, the Company believes there is a significantopportunity to sell additional software products into its customer base and assuch has added two further products to its suite aimed at the finance departmentof US hospitals. In November, Craneware launched Patient Charge Estimator(TM),which enables hospitals to efficiently and accurately provide prospectivepatients with estimates of procedural charges. Yesterday the Company launchedPharmacy ChargeLink(TM) which enables hospitals to improve the buying, billing and reimbursement of pharmacy items. Craneware has started the second half of the year with a strong pipeline ofsales prospects and this together with the new product launches gives managementconfidence for the Company's performance for the full year. Overall, significantprogress has been made in H1 and the Company anticipates further positivenewsflow in H2. Craneware will be announcing Interim results on Tuesday 26thFebruary 2008. Keith Neilson, CEO of Craneware, commented, "We are delighted with the progressmade during the first few months of life as a public company. Cranewarecontinues to grow and we have maintained our leading position as a provider ofrevenue cycle management software to US hospitals. The complexity of legislationgoverning this sector, and the high proportion of hospitals still using manualsolutions to manage their revenue cycles, means we are operating in a vibrantmarketplace with opportunity for growth alongside continuing high levels ofcontract renewals. We look forward to updating shareholders in February." For further information, please contact: Craneware plc KBC Peel Hunt ICIS+44 (0)1506 407 666 +44 (0)20 7418 8900 +44 (0)20 7651 8688Keith Neilson, CEO Oliver Scott Tom MoriartySandy McDougall, CFO Deon Veldtman Caroline Evans-Jones About Craneware Founded in 1999, Craneware has headquarters in Livingston, Scotland, withoffices in Florida, Arizona and Kansas, employing approximately 100 staff. TheCompany's flagship product, Chargemaster Toolkit(R) ("CMT"), assists UShealthcare providers in reducing billing errors, ensuring the timely andaccurate submission of claims and managing compliance risk. More informationabout Craneware plc and its services can be found on-line at the Company'scorporate website, www.craneware.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Oct 20144:25 pmRNSTotal Voting Rights
23rd Sep 201412:30 pmRNSHolding(s) in Company
23rd Sep 201412:25 pmRNSGrant of Options
16th Sep 20147:00 amRNSFinal Results
1st Sep 20145:20 pmRNSIssue of Consideration Shares
28th Aug 20147:00 amRNSBoard Appointment and Acquisition
17th Jul 201410:46 amRNSTransaction in Own Securities, Total Voting Rights
15th Jul 20147:00 amRNSTrading Update
28th Apr 20147:00 amRNSSignificant Contract Win
16th Apr 20145:00 pmRNSBlocklisting Interim Review
11th Apr 201412:05 pmRNSDirector/PDMR Shareholding
4th Apr 20144:27 pmRNSDirector/PDMR Shareholding
2nd Apr 20147:00 amRNSSignificant Contract Wins
31st Mar 20142:29 pmRNSDividend Currency Election
11th Mar 20147:00 amRNSHalf Yearly Report
16th Jan 20147:00 amRNSTrading Update and Notice of Results
22nd Nov 20134:57 pmRNSHolding(s) in Company
15th Nov 20137:00 amRNSDividend Currency Election
12th Nov 20135:52 pmRNSResult of AGM
12th Nov 20137:00 amRNSAGM Statement and Appointment
18th Oct 20131:57 pmRNSPosting of Annual Report, Notice of AGM
30th Sep 20132:20 pmRNSHolding(s) in Company
12th Sep 20136:25 pmRNSDirector/PDMR Shareholding
11th Sep 20134:40 pmRNSDirector/PDMR Shareholding
11th Sep 20138:50 amRNSGrant of Options
10th Sep 20137:00 amRNSFinal Results
12th Jul 20137:00 amRNSNotice of Results
26th Jun 20137:00 amRNSTrading Update
15th Apr 201311:09 amRNSBlocklisting Interim Review
12th Apr 20135:32 pmRNSTotal Voting Rights
18th Mar 20133:30 pmRNSDividend Currency Election
4th Mar 20134:29 pmRNSTotal Voting Rights
27th Feb 201312:29 pmRNSDirector/PDMR Shareholding
26th Feb 20137:00 amRNSHalf Yearly Report
15th Feb 201312:00 pmRNSHolding(s) in Company
21st Jan 20137:00 amRNSTrading Update
30th Nov 201212:41 pmRNSHolding(s) in Company
9th Nov 20127:00 amRNSDividend Currency Election
8th Nov 201211:45 amRNSResult of AGM
8th Nov 20128:00 amRNSAGM Statement
19th Oct 201212:54 pmRNSBlocklisting Interim Review
10th Oct 20125:32 pmRNSPosting of Annual Report & Notice of AGM
24th Sep 20125:22 pmRNSGrant of Options
19th Sep 20125:53 pmRNSHolding(s) in Company
17th Sep 201211:38 amRNSDirector/PDMR Shareholding
6th Sep 201211:35 amRNSDirector/PDMR Shareholding
4th Sep 20127:00 amRNSFinal Results
29th Aug 20127:00 amRNSesMD Certification
15th Aug 20127:00 amRNSNotice of Results
2nd Aug 20122:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.